"The Tate Cancer Center at UM Baltimore Washington Medical Center provides medical, radiation and surgical oncology for many types of cancers."

During the past decade, UM Baltimore Washington Medical Center/Tate Cancer Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 12 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 7 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UM Baltimore Washington Medical Center/Tate Cancer Center" #1 sponsor was "NRG Oncology" with 15 trials, followed by "National Cancer Institute (NCI)" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "Radiation Therapy Oncology Group" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UM Baltimore Washington Medical Center/Tate Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "UM Baltimore Washington Medical Center/Tate Cancer Center" are "Prostate Cancer" (5 trials), "Stage II Breast Cancer" (4 trials), "Breast Cancer" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage II Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "UM Baltimore Washington Medical Center/Tate Cancer Center" in a lesser frequency.

Most popular intervention types in "UM Baltimore Washington Medical Center/Tate Cancer Center" are "Radiation" (35 trials), "Drug" (34 trials), "Other" (30 trials), "Procedure" (14 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (13 trials), "Cisplatin" (9 trials), "Questionnaire Administration" (9 trials), "Intensity-Modulated Radiation Therapy" (8 trials) and "Laboratory Biomarker Analysis" (8 trials). Other intervention names were less common.

The vast majority of trials in "UM Baltimore Washington Medical Center/Tate Cancer Center" are 35 trials for "All" genders, 10 trials for "Male" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "UM Baltimore Washington Medical Center/Tate Cancer Center". undefined are not yet recruiting, 20 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in UM Baltimore Washington Medical Center/Tate Cancer Center, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UM Baltimore Washington Medical Center/Tate Cancer Center, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".